Valiant Laboratories IPO | The pharmaceutical ingredient manufacturing company aims to raise Rs 152.46 crore via maiden public issue of 1.09 crore equity shares comprising only a fresh issue portion.
Valiant Laboratories IPO |that focuses on manufacturing Paracetamol intends to raise Rs 152.46 crore via public issue at the upper price band, which comprises only a fresh issue component.